SCOPUS 정보 검색 플랫폼

Diabetes Care

Volumn 27, Issue 2, 2004, Pages 625-626

A Case of Lipoatrophy with Lispro Insulin Without Insulin Pump Therapy [13]

(3) Arranz, Alfonso a,b Andia, Victor a López Guzmán, Antonio a

a HOSPITAL NUESTRA SEÑORA DE SONSOLES (Spain)

b Endocrinology Unit (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPART; HUMAN INSULIN; INSULIN; INSULIN ANTIBODY; INSULIN LISPRO; ISOPHANE INSULIN; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LETTER; LIPOATROPHY; PATHOGENESIS;

ADULT; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPODYSTROPHY;

EID: 0842289925 PISSN: 01495992 EISSN: None Source Type: Journal
DOI: 10.2337/diacare.27.2.625 Document Type: Letter

Times cited : (31)

References (7)

1
- 0035132210
- Lipoatrophy associated with lispro insulin in insulin pump therapy
- Griffin ME, Feder A, Tamborlane WV: Lipoatrophy associated with lispro insulin in insulin pump therapy (Letter). Diabetes Care 24:174, 2001
- (2001) Diabetes Care , vol.24 , pp. 174
- Griffin, M.E.¹ Feder, A.² Tamborlane, W.V.³

2
- 0043168126
- A new case of lipoatrophy with lispro insulin in insulin pump therapy
- Ampudia-Blasco FJ, Hasbum B, Carmena R: A new case of lipoatrophy with lispro insulin in insulin pump therapy (Letter). Diabetes Care 26:953-954, 2003
- (2003) Diabetes Care , vol.26 , pp. 953-954
- Ampudia-Blasco, F.J.¹ Hasbum, B.² Carmena, R.³

3
- 0034158136
- Human recombinant DNA insulin-induced lipoatrophy in patient with type 2 diabetes mellitus
- Mu L, Goldman JM: Human recombinant DNA insulin-induced lipoatrophy in patient with type 2 diabetes mellitus. Endocr Pract 6:151-152, 2000
- (2000) Endocr Pract , vol.6 , pp. 151-152
- Mu, L.¹ Goldman, J.M.²

4
- 0018849975
- Insulin induced lipoatrophy evidence for an immune pathogenesis
- Reeves WG, Allen BR, Tattersall RB: Insulin induced lipoatrophy evidence for an immune pathogenesis. BMJ 1:1500-1506, 1980
- (1980) BMJ , vol.1 , pp. 1500-1506
- Reeves, W.G.¹ Allen, B.R.² Tattersall, R.B.³

5
- 10244227924
- Insulin-induced lipoatrophy in type 1 diabetes: A possible tumor necrosis factor-α-mediated dedifferentiation of adipocytes
- Atlan-Gepner C, Bondgrand P, Farnarier C, Xerri L, Choux R, Gauthier JF, Brue T, Vague P, Grob JJ, Vialettes B: Insulin-induced lipoatrophy in type 1 diabetes: a possible tumor necrosis factor-α-mediated dedifferentiation of adipocytes. Diabetes Care 19:1283-1285, 1996
- (1996) Diabetes Care , vol.19 , pp. 1283-1285
- Atlan-Gepner, C.¹ Bondgrand, P.² Farnarier, C.³ Xerri, L.⁴ Choux, R.⁵ Gauthier, J.F.⁶ Brue, T.⁷ Vague, P.⁸ Grob, J.J.⁹ Vialettes, B.¹⁰

6
- 0043172522
- Effect of long-term exposure to insulin Lispro on the induction of antibody response in patients with type 1 or type 2 diabetes
- Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH: Effect of long-term exposure to insulin Lispro on the induction of antibody response in patients with type 1 or type 2 diabetes. Diabetes Care 26:89-96, 2003
- (2003) Diabetes Care , vol.26 , pp. 89-96
- Fineberg, S.E.¹ Huang, J.² Brunelle, R.³ Gulliya, K.S.⁴ Anderson, J.H.⁵

7
- 0027241350
- Severe lipoatrophy with human insulin: Successfully treated by CSII
- Chantelau E, Reuter M, Schotes S, Starke AA: Severe lipoatrophy with human insulin: successfully treated by CSII (Letter). Diabet Med 10:580-581, 1993
- (1993) Diabet Med , vol.10 , pp. 580-581
- Chantelau, E.¹ Reuter, M.² Schotes, S.³ Starke, A.A.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.